Opinion
-
Advantages Offered by National Health Access
Opinion -The Health Care Policy Roundtable, a project of the HR Policy Association, has identified six main advantages of the National Health Access program it announced in January. Access to appropriate care. -
Patients Want More Control Over Their Health Care
Opinion -The rapid advance of medical science over the past century means patients now have more therapies available to them than ever before. Historically, patients relied on physicians to provide them with information about medical developments. -
Commentary: No Child Left Unmedicated
Opinion -Big Brother is on the march. A plan to subject all children to mental health screening is underway, and the pharmaceutical firms are gearing up for bigger sales of psychotropic drugs. -
Fixing America’s Health Care System
Opinion -Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer by Sally C. Pipes, with a foreword by Milton Friedman $14. -
Prescription Drug Pricing Attacked, Defended
Opinion -At a January meeting of the National Association of Attorneys General (NAAG) in Chicago, critics of the prescription drug industry unleashed a barrage of attacks on the way the industry prices its product. Most of the criticism was off the mark. -
HSAs Next Big Opportunity for Banks
Opinion -The Business Journal of Minneapolis reports, "Health savings accounts could be the next big business opportunity for banks in 2005. -
Plodding along a Cul-De-Sac
Opinion -If there is one thing most tragic about the ideas promoted by the advocates of national health care, it is that they keep going around in circles, always starting and ending at the same place: more government regulation. -
HHS and Commerce Dept. Reports Oppose Drug Importation
Opinion -In late December, the U.S. Department of Health and Human Services released a long-awaited report on the importation of prescription drugs to the United States. -
New Prescription Drug Web Site Could Mislead Consumers
Opinion -A new Web site purporting to "help consumers and their doctors identify the most effective and affordable medicines" is marred by a pro-generics agenda and bias against newer and more expensive drugs. -
HSAs Bursting Out in New York
Opinion -The New York Daily News reports "a burst of interest [in health savings accounts (HSAs)] now in New York. -
Governor Cuts 320,000 from Ailing Tennessee Health Care Program
Opinion -Governor Phil Bredesen (D) announced in January he would cut insurance coverage to 320,000 Tennesseans in an effort to reform TennCare, the state's troubled, 12-year-old health insurance program. -
White House Summit Lauds Consumer-Driven Health Care Approach
Opinion -President George W. -
Canada Plans to Stop U.S. Drug Importation
Opinion -Citing ethical, safety, and supply concerns, Canadian health officials have begun to draft a proposal that would ban the export of prescription drugs into the United States by retail sales through the Internet and the mail. -
Technocrats’ Takeover Threatens Patient-Oriented Medicine
Opinion -A new report, "How Technocrats Are Taking Over the Practice of Medicine: A Wake-up Call to the American People," written by Twila Brase, president of the Citizens' Council on Health Care (CCHC), challenges the "increasingly touted theory of -
Patients and Physicians Can Cut Drug Costs
Opinion -Consumers have never had more opportunities to obtain information on drugs than they do today. Yet chronically ill patients without drug insurance coverage often spend far more on prescription drugs than necessary. -
Lawsuit Abuse Defeats Real-Life Heroes
Opinion -Last month, my wife and I took two of our three sons to see the film The Incredibles. If you have no young children begging you to see it and you think it has no message applicable to adults, allow me to correct you. -
Campaign for Drug Importation Falters
Opinion -Importing safe and cheap prescription drugs would require a billion-dollar safety net that ultimately would consume most of the potential savings from importing drugs while draining drug research and development funds, according to a December 21 report -
Key Comparisons Between Pro-Medicaid and Pro-Private Pay States
Opinion -"The Long-Term Care Dilemma, What States Are Doing Right and Wrong" profiles five states that could be considered "pro-Medicaid" and five that could be considered "pro-private pay. -
Consumers Confident in Prescription Drugs, AP Study Says
Opinion -An end-of-year Associated Press poll showed that, despite recent product withdrawals and reported health risks of popular medicines, U.S. consumer confidence in the safety of prescription drugs remains high. -
Health Care Info Tech Trade Show Highlights Innovation
Opinion -When Toward an Electronic Patient Record (TEPR), a leading health care technology trade show, takes place in Salt Lake City this May, the event will be celebrating its twenty-first year. -
States’ Drug Import Program Draws Little Interest from Public
Opinion -After three months of operation, only about 1,900 persons have signed up for the I-SaveRx drug import program, which offers low-cost imported drugs to residents of Illinois, Kansas, Missouri, and Wisconsin. The program went into operation last October. -
Insurance-Free Pharmacies Lower Consumers’ Drug Costs
Opinion -Health care reform is, of course, one of the most significant public policy issues facing the United States. The debate, however, tends to focus on government policy and programs, often to the exclusion of private-sector initiatives. -
Medicaid Threatens State Budgets
Opinion -Medicaid spending is on pace to crowd out everything else in state budgets within a generation, according to “The Long-Term Care Dilemma, What States Are Doing Right and Wrong,” a new study jointly produced by the American Legislative Exchange Council -
NAAG Casts Its Eyes on the Drug Industry
Opinion -Earlier this week, the National Association of Attorneys General (NAAG) met in Chicago to discuss "the costs and benefits of prescription drugs." Many of us who have watched NAAG over the years feared for the worst.
